KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion globenewswire.com/NewsRoom/Relea…

$KRTL - KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and Mental Wellness Expansion ibn.fm/KXADq #stocks

“Attention $KRTL shareholders: Sigma Pharmaceuticals has officially been approved to manufacture and distribute animal medications. Stay tuned!”

Attention $KRTL shareholders: We’ve officially started the process of trademarking “KRTL.” A law firm has been retained and paid. More updates soon as we solidify our brand for the future.

Attention $KRTL shareholders: Press release is coming this week, with more potentially on the way!

KRTL Holding Group Inc. Advances in 15c2-11 Process with Court-Approved Shareholder Verification Initiative globenewswire.com/NewsRoom/Relea…

Attention $kRTL Shareholders: A scheduled press release is set for tomorrow, followed by an additional release at a later date.

🚨 Attention $KRTL shareholders: PR is scheduled for tomorrow, with more to follow. Stay tuned. 📢

🚨 Attention $KRTL Shareholders: Management is actively scheduling upcoming Press Releases. Stay tuned for important updates. #KRTL #Investors #PressRelease

🚨 Attention $KRTL shareholders: Management is preparing press releases. One is scheduled for this week following a key third-party approval. Stay tuned. #KRTL #Biotech

$KRTL Q2 Results: KRTL Holding Group reports exceptional Q2 2025 performance with revenue surging 1,927% to $63,358 compared to $3,125 in Q2 2024, driven by the successful launch of consulting services through their expanding business operations.#KRTL #EarningsReport

$KRTL Profitability Update: Net income climbed 137% to $148,618 in Q2 2025 versus $62,790 in the prior year quarter, demonstrating the company's ability to convert increased revenue into bottom-line growth across their biotech and international divisions. #KRTL #NetIncome

📢 Attention $KRTL Shareholders: An updated press release expanding on our March 4, 2025 announcement is forthcoming. Stay tuned for important updates on our progress and next steps. #KRTL #ShareholderUpdate #PressRelease

📢 Attention $KRTL Shareholders: Following our March 24, 2025 announcement, an expanded press release is forthcoming. This update will encompass our progress to date and outline next steps. Stay tuned. #KRTL #Biotech #Shareholder

Attention $KRTL shareholders: PR is scheduled for tomorrow. Congratulations!

KRTL Holding Group, Inc. Announces Merger with Industria Químico Farmacéutica Sigma Corp. S.R.L. globenewswire.com/NewsRoom/Relea…

KRTL Biotech Highlights ELIXIR as Flagship Hydration Product in Bolivia globenewswire.com/NewsRoom/Relea…

📢 Shareholder Alert $KRTL: This Thursday, KRTL will release a new press announcement highlighting our international Pain Management portfolio — including data from SIGMA’s FY2025 Bolivian operations. This update reflects continued value from our cross-border integration

KRTL Biotech Spotlights Anti-Infectives and Antibiotics Portfolio to Support Public Health and Global Treatment Access globenewswire.com/NewsRoom/Relea…

krtl-icc.com/post/krtl-hold…